---
title: "華檢醫療控股有限公司 (01931.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/01931.HK.md"
symbol: "01931.HK"
name: "華檢醫療控股有限公司"
industry: "醫療產品分銷商"
---

# 華檢醫療控股有限公司 (01931.HK)

| Item | Detail |
|------|--------|
| Industry | 醫療產品分銷商 |
| Location | 港股市場 |
| Website | [www.ethk.com](https://www.ethk.com) |

## Company Profile

華檢醫療控股有限公司是一家主要從事銷售及製造醫療設備及耗材,並提供與醫療設備有關的售後服務的投資控股公司。該公司通過叁個分部開展業務。分銷業務分部主要向分銷商、醫院及醫療機構以及物流提供商等客戶分銷體外診斷產品(IVD)分析儀、試劑及其他耗材。售後服務分部主要提供維護及維修服務、安裝服務及終端客戶培訓服務。自有品牌產品業務分部從事研究、開發、生產及銷售IVD分析儀及試劑。該公司主要在中國國內市場開展其業務。

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:10.000Z

**Overall: C (0.45)**

**Industry**: Health Care Distributors

| Metric | Value |
|--------|-------|
| Industry Ranking | 7 / 21 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.61% |  |
| Net Profit YoY | -32.99% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.49 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 1.86B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 3.34B |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 5.08% | C |
| Profit Margin | 5.66% | C |
| Gross Margin | 22.02% | D |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 0.61% | C |
| Net Profit YoY | -32.99% | D |
| Total Assets YoY | 17.75% | A |
| Net Assets YoY | 4.45% | C |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 1766.73% | B |
| OCF YoY | 0.61% | C |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.54 | C |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 42.78% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 華檢醫療控股有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "5.08%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "5.66%",
          "rating": "C"
        },
        {
          "name": "Gross Margin",
          "value": "22.02%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "0.61%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-32.99%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "17.75%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "4.45%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "1766.73%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "0.61%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.54",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "42.78%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 藥師幫 (HK.9885) | C | B | A | D | B | B |
| 02 | GUANZE MEDICAL (HK.2427) | B | A | C | A | B | B |
| 03 | 君百延集團 (HK.8372) | B | B | B | A | B | B |
| 04 | 上海醫藥 (HK.2607) | C | C | A | D | B | C |
| 05 | 白雲山 (HK.874) | C | C | A | C | B | C |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 10.08 | 6/23 | 55.01 | 17.80 | 9.97 |
| PB | 0.51 | 5/23 | 3.41 | 0.98 | 0.74 |
| PS (TTM) | 0.57 | 13/23 | 3.97 | 1.13 | 0.82 |
| Dividend Yield | 0.00% | - | 3.06% | 2.96% | 2.52% |

## References

- [Company Overview](https://longbridge.com/en/quote/01931.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/01931.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/01931.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.